Home » Clinical Trials » EMBARC-AIRNET: The EMBARC Anti-Inflammatory Repurposing Network

Research area:

Chronic respiratory infection

Disease:

Bronchiectasis

Intervention:

Therapeutics – Small molecules

Phase:

Phase II

EMBARC-AIRNET: The EMBARC Anti-Inflammatory Repurposing Network

Intervention

Therapeutics – Small molecules

Funding awarded to

University of Dundee

Public registration details (where available)

ISRCTN17596258

Planned trial start and expected end date

July 2024 to February 2027

Related news

Dementia Consortium funds Manchester based team targeting immune system in search for new dementia treatments

Read more: Dementia Consortium funds Manchester based team targeting immune system in search for new dementia treatments

MRC Technology invests £7 million to expand its diagnostics research capability in Scotland

Read more: MRC Technology invests £7 million to expand its diagnostics research capability in Scotland

UK Drug Discovery Consortium symposium

Read more: UK Drug Discovery Consortium symposium